CGEN
CGEN
NASDAQ · Biotechnology

Compugen Ltd

$1.67
+0.08 (+5.03%)
As of Feb 8, 2:07 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 14.58M 13.34M 13.91M
Net Income 2.88M 3.22M 3.61M
EPS
Profit Margin 19.8% 24.2% 26.0%
Rev Growth -8.4% -7.1% -8.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 49.00M 44.00M 47.56M
Total Equity 75.78M 75.57M 70.88M
D/E Ratio 0.65 0.58 0.67
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 4.55M 4.43M 4.67M
Free Cash Flow 4.06M 3.77M 3.36M